Rankings
▼
Calendar
LNTH Q1 2020 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena
LNTH
Lantheus Holdings, Inc.
$5B
Q1 2020 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$91M
+4.8% YoY
Gross Profit
$38M
41.9% margin
Operating Income
$7M
7.9% margin
Net Income
$3M
3.7% margin
EPS (Diluted)
$0.08
QoQ Revenue Growth
+1.5%
Cash Flow
Operating Cash Flow
$9M
Free Cash Flow
$7M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$404M
Total Liabilities
$286M
Stockholders' Equity
$118M
Cash & Equivalents
$96M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$91M
$87M
+4.8%
Gross Profit
$38M
$44M
-13.8%
Operating Income
$7M
$16M
-55.9%
Net Income
$3M
$10M
-66.5%
Revenue Segments
DEFINITY
$57M
71%
Techne Lite
$23M
29%
← FY 2020
All Quarters
Q2 2020 →